These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15225421)

  • 1. [Study of the correlation between drug exposure and blood concentration during cyclosporine microemulsion absorption phase in Chinese adult liver transplant recipients].
    Chen G; He Y; Chen YC; Wang HZ; Chen JH; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):328-30. PubMed ID: 15225421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis.
    Internation Neoral Renal Transplantation Study Group
    Am J Transplant; 2002 Feb; 2(2):157-66. PubMed ID: 12099518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S; Vareesangthip K; Ong-ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.
    Trompeter R; Fitzpatrick M; Hutchinson C; Johnston A
    Pediatr Transplant; 2003 Aug; 7(4):282-8. PubMed ID: 12890006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.
    International Neoral Renal Transplantation Study Group.
    Am J Transplant; 2002 Feb; 2(2):148-56. PubMed ID: 12099517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A absorption profiles in children with nephrotic syndrome.
    Nozu K; Iijima K; Sakaeda T; Okumura K; Nakanishi K; Yoshikawa N; Honda M; Ikeda M; Matsuo M
    Pediatr Nephrol; 2005 Jul; 20(7):910-3. PubMed ID: 15856324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A; Steel L; Sharples L; Stewart S; Parameshwar J; McNeil K; Wallwork J
    Ther Drug Monit; 1999 Feb; 21(1):17-26. PubMed ID: 10051050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients.
    Kelles A; Herman J; Tjandra-Maga TB; Van Damme-Lombaerts R
    Pediatr Transplant; 1999 Nov; 3(4):282-7. PubMed ID: 10562972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
    Solari SG; Goldberg LR; DeNofrio D; Shaw LM
    Ther Drug Monit; 2005 Aug; 27(4):417-21. PubMed ID: 16044096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for monitoring cyclosporine concentration at 2 hours after administration in infants posttransplantation.
    Furlan V; Lykavieris P; Maubert MA; Habes D; Debray D
    Transplant Proc; 2009 Oct; 41(8):3333-4. PubMed ID: 19857744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2002 Feb; 24(1):40-6. PubMed ID: 11805721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients.
    Frassetto LA; Tan-Tam CC; Barin B; Browne M; Wolfe AR; Stock PG; Roland M; Benet LZ
    Transplantation; 2014 Mar; 97(6):702-7. PubMed ID: 24389906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the therapeutic drug monitoring of cyclosporine.
    Citterio F
    Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
    Iversen M; Nilsson F; Sipponen J; Eiskjaer H; Mared L; Bergan S; Nyström U; Fagertun HE; Solbu D; Simonsen S
    J Heart Lung Transplant; 2009 Sep; 28(9):919-26. PubMed ID: 19716045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation.
    Mahalati K; Belitsky P; Sketris I; West K; Panek R
    Transplantation; 1999 Jul; 68(1):55-62. PubMed ID: 10428267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.